Carcinoma, Hepatocellular  >>  Pexa-Vec (pexastimogene devacirepvec)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pexa-Vec (pexastimogene devacirepvec) / SillaJen, Transgene
NCT00629759: A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma

Completed
1
14
RoW
JX-594: Recombinant vaccinia virus (TK-deletion plus GM-CSF)
Jennerex Biotherapeutics, Green Cross Corporation
Neoplasms, Liver
07/07
08/07

Download Options